Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
AK3 pseudogene 5 (AK3P5) is classified as a **pseudogene** of the adenylate kinase 3 (AK3) gene[1]. Pseudogenes are DNA sequences similar to known genes but are generally non-functional due to mutations or lack of regulatory elements required for protein expression[2]. There is no evidence that AK3P5 encodes a functional protein or acts as a direct therapeutic target, receptor, enzyme, or transporter. Unlike its parental gene AK3, which encodes a mitochondrial enzyme involved in nucleotide metabolism, pseudogenes such as AK3P5 typically do not have biological functions or direct disease relevance established in the literature[1][2][5]. Literature references concentrate on the properties and functions of the functional AK3 gene but make no mention of AK3P5 as a clinically or pharmacologically relevant entity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on AK3 pseudogene 5 (AK3P5).